News

December 11, 2023, Moscow. –  The Association of International Pharmaceutical Manufacturers (AIPM) announces that Vladimir Shipkov resigns from the post of Executive Director of the Association. The decision was adopted at the General Meeting of the AIPM member-companies, held on December 6, 2023.

July 06, 2022, Moscow – Association of International Pharmaceutical Manufacturers (AIPM) announces extension of the list of members. The biopharmaceutical company Sobi was admitted a member of the AIPM in line with the Statues of the Association following the general vote of the member-companies.

The Association of International Pharmaceutical Manufacturers confirms the principled readiness of the member companies of the Association to continue supplies of medicines for patients of the Russian Federation.

February 04, 2022, Moscow - the Association of International Pharmaceutical Manufacturers (AIPM) announces that Natalya Kolerova, President of Novartis Group of Companies in Russia, was elected as the Chair of the Board of Directors of the Association of International Pharmaceutical Manufacturers and Anthony Wong, Regional Vice President for AbbVie's business in Russia and the CIS region, was elected as the Vice-Chairman of the Board of Directors of the Association of International Pharmaceutical Manufacturers.

June 11, 2021, Moscow – Representatives of the Eurasian Economic Commission (EEC) and the Association of International Pharmaceutical Manufacturers (AIPM) held the working meeting on the development of the single market of medicines in the EAEU.

May 13, 2021, Saint Petersburg — COVID-19 has had a significant impact on the socio-economic development of countries and especially with regards to the healthcare. For more than a year now, the world has been living in completely new conditions, and the pharmaceutical industry has made an important contribution in the efforts to find out optimal solutions to handling the fallout from the health crisis. During the press briefing of the Association of International Pharmaceutical Manufactures (AIPM), traditionally held during the Russian Pharmaceutical Forum in St. Petersburg, heads of the leading international companies and representatives of the patient community shared their vision of the key challenges and lessons learned following the start of pandemic. They also discussed emerging trends in development of regulatory environment, as well as what further steps are needed to successfully achieve the national healthcare goals. Almost each speaker brought attention to the point that current interaction mode demonstrates how successful the healthcare solutions might be if developed through close cooperation between regulators and the industry on regular bases, how significantly grew speed in decision-making across all sectors of the healthcare, while also stressing the need to focus on the patient-centricity when developing all state programs or initiatives. 

December 14, 2020, Moscow - The Association of International Pharmaceutical Manufacturers (AIPM) announces an addition to its membership.  Pursuant to a resolution of the General Meeting, the STADA pharmaceutical company has been admitted to AIPM.  

It reflects the extreme concern of the professional community about the risk of interruptions in the supply of medicines to the population of the Russian Federation in connection with the expected introduction of the Trace & Track system for medicines as of July 01, 2020. 

• The changes in the regulation environment and transition to digital interactions, which were aimed at fighting against COVID-19, have proven to be effective. This experience should be broadly exploited in the future to deal with other challenges that the national healthcare system is facing.

April 9, 2020, Moscow – The international pharmaceutical industry reaffirms its global and regional commitment to attract the industry expertise and know-how needed to accelerate the development of safe and effective new vaccines, diagnostics and treatments to use in the fight against COVID-19 in collaboration with all stakeholders. In context of the COVID-19 pandemic and unprecedented challenges for public healthcare, companies and leading global industry associations – IFPMA (International Federation of Pharmaceutical Manufacturers & Association) and EFPIA (European Federation of Pharmaceutical Industries and Associations), of which AIPM is a member – have voiced their willingness to support public healthcare systems around the world during these difficult times.

February 26, 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that Board of Directors has confirmed the authority of Vasily Ignatiev, CEO of R-Pharm, as Vice Chairman of the AIPM Board of Directors for the second term.

3 February 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Directors Mrs. Oxana Monge, General Manager, Sanofi Eurasia, has been elected the Chair of the Board of Directors at AIPM.

Introduction of the Track&Trace system for medicines has been discussed at Izvestiya Multimedia Information Center (MIC).

Representatives of the EEC and regulatory authorities of EAEU member-states, industry associations and the sector in cooperation with the leading international experts discussed the prospects, key challenges and law enforcement issues in creation of the common market of medicines in the EAEU and EU. 

Representatives of the Association of International Pharmaceutical Manufacturers talk about their contribution to achieving key national health indicators: #aipm25to80, #pharma_onthewayto80, #вместеради80плюс, #aipm25